Article Text
Abstract
Aims To evaluate the quality of responses from large language models (LLMs) to patient-generated conjunctivitis questions.
Methods A two-phase, cross-sectional study was conducted at the Eye and ENT Hospital of Fudan University. In phase 1, four LLMs (GPT-4, Qwen, Baichuan 2 and PaLM 2) responded to 22 frequently asked conjunctivitis questions. Six expert ophthalmologists assessed these responses using a 5-point Likert scale for correctness, completeness, readability, helpfulness and safety, supplemented by objective readability analysis. Phase 2 involved 30 conjunctivitis patients who interacted with GPT-4 or Qwen, evaluating the LLM-generated responses based on satisfaction, humanisation, professionalism and the same dimensions except for correctness from phase 1. Three ophthalmologists assessed responses using phase 1 criteria, allowing for a comparative analysis between medical and patient evaluations, probing the study’s practical significance.
Results In phase 1, GPT-4 excelled across all metrics, particularly in correctness (4.39±0.76), completeness (4.31±0.96) and readability (4.65±0.59) while Qwen showed similarly strong performance in helpfulness (4.37±0.93) and safety (4.25±1.03). Baichuan 2 and PaLM 2 were effective but trailed behind GPT-4 and Qwen. The objective readability analysis revealed GPT-4’s responses as the most detailed, with PaLM 2’s being the most succinct. Phase 2 demonstrated GPT-4 and Qwen’s robust performance, with high satisfaction levels and consistent evaluations from both patients and professionals.
Conclusions Our study showed LLMs effectively improve patient education in conjunctivitis. These models showed considerable promise in real-world patient interactions. Despite encouraging results, further refinement, particularly in personalisation and handling complex inquiries, is essential prior to the clinical integration of these LLMs.
- Ocular surface
- Conjunctiva
- Medical Education
Data availability statement
All data relevant to the study are included in the article or uploaded as online supplemental information.
Statistics from Altmetric.com
Data availability statement
All data relevant to the study are included in the article or uploaded as online supplemental information.
Footnotes
JW and RS contributed equally.
Contributors JW and RS shared the first authorship. JH, YH, XZ, RS and JW contributed to the concept and design of the study. RS was responsible for the design and data collection of phase 1. JH, QL, KS, XZ and ZC provided support for the data collection in Phase 1 and the recruitment of conjunctivitis patients in phase 2. JW and RS were responsible for data collection for phase 2. JW performed the statistical analysis for the entire study and took charge of manuscript writing. JH secured funding, supervised the study and served as its guarantor.
Funding This study was funded by the National Natural Science Foundation of China (82171102, 81970766, 82271044), the National Key Research and Development Program of China (2023YFA0915000), the Shanghai Medical Innovation Research Program (22Y21900900), the Shanghai Key Clinical Research Program (SHDC2020CR3052B).
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.